Consistent with our findings is the demonstration that co-expression of FSTL1 with p53 associates with poor prognosis, in patients with glioblastoma [10], thus reinforcing the concept that FSTL1 can sustain signals that amplify tumorigenesis. This evidence concerns the gene TP53 and glioblastoma.